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Recently it was found that trmasgenic naiee, that overexpress SCNNIB, pre~ent CF fike lung 
disease symptoms (Mall et al. (2004) Nat Med 10, 487). Mutations ha SCNNIB may therefore 
potentially explain disease in CF patients in whom a mutation cannot be identified on both 
CFTR genes. The complete coding region f the SCNNIB gene, aud exonfinta~n junctions, was 
~eqnenced in 8 patients in whom a mutation could not be identified on both CFTR genes. One 
patient, who was heterowgous for the F308del CFTR mutation, was heterozygous for the 
S82C~qCNNIB mutation. Imerestingly, her sister, who also has CE carried the ~rne genotype. 
Another patient, who was heterozygous for the M952T CFTR mutaticta, was heterozygous for 
the G589S SCNN1B mutation. Heterozygosity for a CFTR mutation aud a SCNNIB mutation 
might hus result indisease. In the remaizfing patients, no SCNN1B mutatic~ could be found 
and therefore the complete coding region, mad exon/intaon junctions, of the SCNNIA and 
SCNNIG genes were sequenced too. Apart fl~m the frequent T663A SCNNIA polymorphisna 
and several silent mutations ~,0olymorphiauas in SCNNIG, the W493R SCNNIA mutation was 
found in heterozygons state in one patient in whom no CFTR mutation was found. A multiplex 
single nucleotide primer extension assay was developed for scree~fing for all these 
mutatlonsTpolymorphiauas in conrail individuals and parents of CF patients. Indeed, i f  
heterozygosity for a CFTR mutation and a mutation/polymorphiaua ha ma ENaC sulxmit causes 
disease, such ENaC mutations should be fotmd at lower frequencies ha ealthy CF cea~iers. 
Comp,~red to conU~ls, the disUibution of several SCNNIG polymorliaiauas in healthy CF 
carriers was sigtfi ficmat ly different, mad different (not sigtfi ficaut ly, possibly due to the arnall 
sample size) ha patients without two CFTR mutations. $82C SCNN1B was found at a 
frequency of 2% in conU~ls. Preliminary fimctional characterization i  cocytes showed that 
S82C~qCNN1B, aud T663A SCNN1A (in contrast o Samaha eta/. (2004) J ~iol Chem 279, 
93900) do not gt~z~sly affect he ENaC aud CFTR properties. 
ha smamam~, although farm a genetic point of view it appears that ENaC may be involved in 
mine CF patients in whom a mutation cannot be found on both CFTR genes, the sigtfificance 
of these findings at the fimctioual level is still not clear mad requires furiher investigation. 
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Genotype/phenotype correlation in "atypical" CF clinical pictures 
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The clinical manifestations in OJslic Fibrosis are quite heterogeneous and patients 
with atypical features have recently been described. These patients are commonly 
pancreatic sufficient, have normal or borderline i40 60mMol/ l )  sweat chloride 
concentrations and often have symptoms involving a single organ. This seems to be 
related to the presence of two CFTR gene mutations one of which is not severe, 
resulting in some residual CFTR protein expression mad function. The wide range 
of symptoms makes diagnosis of CF more difficult mad delayed. 
Aims: To analyse genotype and phenotype in patients with monosymptomatic 
manithstations of CE
Methods: We studied 117 subjects of whom 46 had respirator3, dysfunction, 26 
CBAVD, 8 idiopathic pancreatitis and 37 were neonates with positive IRT mad 
borderline sweat test. CFTR coding tract screening was performed using DHPLC 
technique and direct sequencing. 
Results: Genetic analysis led to identification of 53/117 (45.3%) compounds 
heterozygotes, 57/117 heterozygotes (48.7%), 19 of them with the IVSST5 TG12 
haplotype and 2/117 (1.7%) homozygotes for mild mutations. In 5/117 (4.3%) no 
CFTR mutation could be identified; one of them was homozygous IVSST5 TG12 
haplotype, suggesting its possible role ha the pathogenesis of CF when occurs in this 
genetic pattern. 
Cmwlusions: These data provide further evidence that the high degree of the clinical 
heterogeneity in CF is related to the wide genetic variabil ity which causes, rather 
than a loss of protein function, a "gradient" of CFTR dysfunction. 
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The Burkholderia cepaeia (BC) complex is an important oppotttufistic pathogen 
with belongs to a diverse group of bacteria, founded on cystic fibrosis (CF) patients. 
The objective of this study was collect data from this pathogen between CF patients 
ha Campinas, we  performed a genetic evaluation of isolated cultures mad direct 
analysis of the sputum. Samples of expectorated sputum collected from 76 CF 
patients in 2CO3, were inoculated in a specific culture (BCmedium), and 9 patients 
(11.84%) presented a positive culture. In the direct analysis of the sputum, were 
analyzed 59 patients, collected between Apri l  and August of 2004. We pr c~eed the 
analysis by a PCR of the recA gene, specific to the BC complex, fol lowed to the 
specific al lele amplif ication of the genomovars (G) I to V. From the 9 patients, 21 
cultures were isolated, and ha 19 the DNA was successfully extracted. In all the 19 
cultures, the amplif ication of the recA gene was positive. The prevalence of the GIII 
was 12/19 samples (63.15%), of GII was 11/19 (57.59%). The GI, GIV mad GV 
presented a prevalence of 15.78%, 5.26% and 5.26% respectively, ha the direct 
analysis of the sputum, 7 of 59 samples showed to be positive (11.82%). The 
prevalence of the GIII was 1/7 samples (14.28%), whi le  from the GII was 3/7 
(42.86%). The GI, GIV and GV presented a prevalence of 14.28%, 14.28% and 0% 
respectively. The detection of BC by the growth in a specific culture mad by PCR 
analysis of the sputum showed the same prevalence of this pathogen (c[ED] 2 0.0; 
P=0.99). Although, when the complex was analyzed, a rouge variation between the 
genomovars was found. 
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Inadequate levels of functional Cystic Fibrosis Transmembrane Conductance 
Regulator (CFI'R) protein may originate atypical forms of Cystic Fibrosis (CF). 
These genotypes often consist of a classic mutation on one al lele together with an 
intronic or silent exonic sequence variation, producing anomalous CFI'R splicing, 
on the other. 
In a genotype/phenotype calf elation study, we searched for intronic or silent exonic 
sequence variations in subjects with hypertrypsinaemia at birth or affected by sine 
causa semen hyperviscosity or by infertility due to Congenital Bi lateral Absence of 
the Vas Deferens. We could select 6 silent exonic sequence variations and 26 
intr onic ones, 10 of which never sofar described. For 9 of these sequence variations, 
a frequency comparison in the target populations and in a negative control general 
population was performed. The target populations, as compared with consols, 
exhibited higher frequencies of (TG)mT n variant tracts (intron 8), reportedly 
involved in defective splicing, and of (GATT) 6 repetition and/or of 1COl+l l  CFF 
substitution that are both located in intron 6b and have, unti l  now, no assigned 
functional role. Other sequence variations were individually found ha subjects of 
target populations; some other showed no significant differences between the 
different populations. 
Some of those sequence variations with higher frequencies, or individually found, 
in the target populations, are actually under functional studies by RT PCR, starting 
from RNA extracted from cells obtained by nasal brushing. 
